Skip to main content
TipRanks
Go Ultimate75% OFF

Rising Biosciences (RBII) Ratios

21 Followers

Rising Biosciences Ratios

RBII's free cash flow for Q? was ―. For the fiscal year, RBII's free cash flow was increased by ― and operating cash flow was ―. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 20Dec 19
Liquidity Ratios
Current Ratio0.120.00
Quick Ratio0.100.00
Cash Ratio0.030.00
Solvency Ratio0.05-0.14
Operating Cash Flow Ratio-0.04-0.04
Short-Term Operating Cash Flow Coverage-0.07-0.06
Net Current Asset Value$ -1.52M$ -1.56M
Leverage Ratios
Debt-to-Assets Ratio1.652.37
Debt-to-Equity Ratio-0.97-0.82
Debt-to-Capital Ratio-31.66-4.48
Long-Term Debt-to-Capital Ratio0.000.00
Financial Leverage Ratio-0.59-0.35
Debt Service Coverage Ratio0.14-0.14
Interest Coverage Ratio4.09-2.43
Debt to Market Cap0.831.87
Interest Debt Per Share0.000.00
Net Debt to EBITDA6.60-6.49
Profitability Margins
Gross Profit Margin57.32%-42.10%
EBIT Margin15.23%-109.48%
EBITDA Margin19.52%-89.01%
Operating Profit Margin36.33%-109.48%
Pretax Profit Margin6.36%-154.66%
Net Profit Margin6.36%-154.66%
Continuous Operations Profit Margin6.36%-154.66%
Net Income Per EBT100.00%100.00%
EBT Per EBIT17.51%141.27%
Return on Assets (ROA)7.77%-63.30%
Return on Equity (ROE)-4.57%21.88%
Return on Capital Employed (ROCE)-26.08%15.49%
Return on Invested Capital (ROIC)-851.75%84.96%
Return on Tangible Assets7.77%-63.30%
Earnings Yield3.91%-50.02%
Efficiency Ratios
Receivables Turnover6.460.00
Payables Turnover6.874.78
Inventory Turnover8.450.00
Fixed Asset Turnover2.850.54
Asset Turnover1.220.41
Working Capital Turnover Ratio-0.510.00
Cash Conversion Cycle46.54-76.39
Days of Sales Outstanding56.480.00
Days of Inventory Outstanding43.210.00
Days of Payables Outstanding53.1576.39
Operating Cycle99.690.00
Cash Flow Ratios
Operating Cash Flow Per Share-0.00-0.00
Free Cash Flow Per Share-0.00-0.00
Dividend Paid and CapEx Coverage Ratio-23447.67-0.73
Capital Expenditure Coverage Ratio-23447.67-0.73
Operating Cash Flow Coverage Ratio-0.07-0.06
Operating Cash Flow to Sales Ratio-0.09-0.36
Free Cash Flow Yield-5.53%-27.80%
Valuation Ratios
Price-to-Earnings (P/E) Ratio25.56-2.00
Price-to-Sales (P/S) Ratio1.633.09
Price-to-Book (P/B) Ratio-1.17-0.44
Price-to-Free Cash Flow (P/FCF) Ratio-18.08-3.60
Price-to-Operating Cash Flow Ratio-18.08-8.52
Price-to-Earnings Growth (PEG) Ratio-0.260.00
Enterprise Value Multiple14.93-9.96
Enterprise Value2.28M1.45M
EV to EBITDA14.93-9.96
EV to Sales2.918.87
EV to Free Cash Flow-32.41-10.31
EV to Operating Cash Flow-32.41-24.43
Tangible Book Value Per Share-0.00-0.00
Shareholders’ Equity Per Share-0.00-0.00
Tax and Other Ratios
Effective Tax Rate0.000.00
Revenue Per Share0.000.00
Net Income Per Share0.00-0.00
Tax Burden1.001.00
Interest Burden0.421.41
Research & Development to Revenue0.000.00
SG&A to Revenue0.000.00
Stock-Based Compensation to Revenue0.000.00
Income Quality-1.410.23

Currency in USD